Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABBV
MRK
Add up to 3 more stocks
ABBV
AbbVie Inc.
+0.81%
$257.06+2.06Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$454.17B
52W Range
$190.75 - $267.47
MRK
Merck & Co., Inc.
-0.54%
$143.94-0.78Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$355.49B
52W Range
$77.58 - $156.92
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 72.43 | 115.15 |
| Forward P/E | 18.32 | 52.41 |
| P/B Ratio | N/A | 8.48 |
| P/S Ratio | 7.05 | 5.35 |
| P/FCF Ratio | 25.03 | 22.13 |
| EV/EBITDA | 19.34 | 22.76 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.5% | 75.4% |
| Operating Margin | 29.3% | 36.2% |
| Net Margin | 9.8% | 4.8% |
| ROE | N/A | 7.6% |
| ROA | 4.7% | 2.4% |
| ROIC | 13.5% | 5.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.81 | 1.32 |
| Quick Ratio | 0.69 | 1.10 |
| Debt/Equity | N/A | 1.29 |
| Interest Coverage | 6.94 | 17.31 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.7% | 2.3% |
| Payout Ratio | 192.4% | 268.8% |
| Yrs of Dividend Growth | 52 | 15 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.